Terms: = Leukemia AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Diagnosis
16 results:
1. A case report of a blueberry muffin baby caused by congenital self-healing indeterminate cell histiocytosis.
Koster SBL; Vinke ME; van den Bos C; van Heel WJM; Kranendonk MEG; Natté R; van Tuyll van Serooskerken AM
BMC Pediatr; 2023 Mar; 23(1):111. PubMed ID: 36890472
[TBL] [Abstract] [Full Text] [Related]
2. Advances in the Treatment of Hairy Cell leukemia Variant.
Tran J; Gaulin C; Tallman MS
Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?
Matutes E
Expert Rev Hematol; 2021 Apr; 14(4):355-363. PubMed ID: 33759673
[TBL] [Abstract] [Full Text] [Related]
4. map2k1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
[TBL] [Abstract] [Full Text] [Related]
5. Latest Advances in the diagnosis and Treatment of Large Granular Lymphocytic leukemia.
Moignet A; Lamy T
Am Soc Clin Oncol Educ Book; 2018 May; 38():616-625. PubMed ID: 30231346
[TBL] [Abstract] [Full Text] [Related]
6. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Xerri L; Adélaïde J; Popovici C; Garnier S; Guille A; Mescam-Mancini L; Laurent C; Brousset P; Coze C; Michel G; Chaffanet M; Bouabdallah R; Coso D; Bertucci F; Birnbaum D
Am J Surg Pathol; 2018 Feb; 42(2):150-159. PubMed ID: 29194093
[TBL] [Abstract] [Full Text] [Related]
7. High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.
Papo M; Diamond EL; Cohen-Aubart F; Emile JF; Roos-Weil D; Gupta N; Durham BH; Ozkaya N; Dogan A; Ulaner GA; Rampal R; Kahn JE; Sené T; Charlotte F; Hervier B; Besnard C; Bernard OA; Settegrana C; Droin N; Hélias-Rodzewicz Z; Amoura Z; Abdel-Wahab O; Haroche J
Blood; 2017 Aug; 130(8):1007-1013. PubMed ID: 28679734
[TBL] [Abstract] [Full Text] [Related]
8. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
[TBL] [Abstract] [Full Text] [Related]
9. Hairy cell leukaemia-variant: Disease features and treatment.
Matutes E; Martínez-Trillos A; Campo E
Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
[TBL] [Abstract] [Full Text] [Related]
10. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
[TBL] [Abstract] [Full Text] [Related]
11. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic leukemia.
George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
[TBL] [Abstract] [Full Text] [Related]
12. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.
Jones CL; Gearheart CM; Fosmire S; Delgado-Martin C; Evensen NA; Bride K; Waanders AJ; Pais F; Wang J; Bhatla T; Bitterman DS; de Rijk SR; Bourgeois W; Dandekar S; Park E; Burleson TM; Madhusoodhan PP; Teachey DT; Raetz EA; Hermiston ML; Müschen M; Loh ML; Hunger SP; Zhang J; Garabedian MJ; Porter CC; Carroll WL
Blood; 2015 Nov; 126(19):2202-12. PubMed ID: 26324703
[TBL] [Abstract] [Full Text] [Related]
13. [Chronic B-cell lymphoproliferative disorders with hairy cells].
Troussard X; Cornet É
Ann Biol Clin (Paris); 2015; 73(4):399-406. PubMed ID: 25858127
[TBL] [Abstract] [Full Text] [Related]
14. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of cancer stem cells in chronic myeloid leukaemia.
Jørgensen HG; Holyoake TL
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348
[TBL] [Abstract] [Full Text] [Related]
16. leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract] [Full Text] [Related]
